CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2024

Feb 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-02-15

Reporting Person: Tierney David S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-15	Common Stock, Par Value $0.001 per share	M	4000	—	Acquired	348874	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-15	Restricted Stock Units	$	M	4000	Disposed		Common Stock (4000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.

F2: Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025.

F3: Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on February 15, 2024.